Willin/FRMD6 is also co-localized with c-Met in the nuclei of GBM cells, suggesting that Willin/FRMD6 may negatively regulate c-Met functions such as calcium signaling in the nucleus [74,75]. The gene discussed is FRMD6; the disease is glioblastoma.